515120 创新药ETF
已收盘 02-10 14:59:59
资讯
新帖
简况
【ETF动向】2月5日广发中证香港创新药ETF(QDII)基金跌0.95%，份额增加5.18亿份
证券之星 · 02-06
【ETF动向】2月5日广发中证香港创新药ETF(QDII)基金跌0.95%，份额增加5.18亿份
【ETF动向】2月4日广发中证香港创新药ETF(QDII)基金涨1.28%，份额增加1.24亿份
证券之星 · 02-05
【ETF动向】2月4日广发中证香港创新药ETF(QDII)基金涨1.28%，份额增加1.24亿份
【ETF动向】1月30日广发中证香港创新药ETF(QDII)基金跌2.46%，份额增加7450万份
证券之星 · 01-31
【ETF动向】1月30日广发中证香港创新药ETF(QDII)基金跌2.46%，份额增加7450万份
【ETF动向】1月27日广发中证香港创新药ETF(QDII)基金涨0.39%，份额增加1.3亿份
证券之星 · 01-28
【ETF动向】1月27日广发中证香港创新药ETF(QDII)基金涨0.39%，份额增加1.3亿份
【ETF动向】1月5日广发中证香港创新药ETF(QDII)基金涨5.95%，份额减少1.96亿份
证券之星 · 01-06
【ETF动向】1月5日广发中证香港创新药ETF(QDII)基金涨5.95%，份额减少1.96亿份
【ETF动向】12月30日广发中证香港创新药ETF(QDII)基金跌1.55%，份额增加9500万份
证券之星 · 2025-12-31
【ETF动向】12月30日广发中证香港创新药ETF(QDII)基金跌1.55%，份额增加9500万份
【ETF动向】12月15日广发中证香港创新药ETF(QDII)基金跌3.23%，份额增加2.14亿份
证券之星 · 2025-12-16
【ETF动向】12月15日广发中证香港创新药ETF(QDII)基金跌3.23%，份额增加2.14亿份
12月15日博瑞医药跌6.09%，国泰上证科创板创新药ETF基金重仓该股
证券之星 · 2025-12-15
12月15日博瑞医药跌6.09%，国泰上证科创板创新药ETF基金重仓该股
【ETF动向】12月8日广发中证香港创新药ETF(QDII)基金跌0.98%，份额增加1.22亿份
证券之星 · 2025-12-09
【ETF动向】12月8日广发中证香港创新药ETF(QDII)基金跌0.98%，份额增加1.22亿份
【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金跌1.73%，份额增加1.14亿份
证券之星 · 2025-12-04
【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金跌1.73%，份额增加1.14亿份
【ETF动向】11月13日广发中证香港创新药ETF(QDII)基金涨4.2%，份额减少1.89亿份
证券之星 · 2025-11-14
【ETF动向】11月13日广发中证香港创新药ETF(QDII)基金涨4.2%，份额减少1.89亿份
【ETF动向】11月10日广发中证香港创新药ETF(QDII)基金涨1.36%，份额增加1.12亿份
证券之星 · 2025-11-11
【ETF动向】11月10日广发中证香港创新药ETF(QDII)基金涨1.36%，份额增加1.12亿份
【ETF动向】11月6日广发中证香港创新药ETF(QDII)基金涨0.45%，份额增加1.6亿份
证券之星 · 2025-11-07
【ETF动向】11月6日广发中证香港创新药ETF(QDII)基金涨0.45%，份额增加1.6亿份
广发中证香港创新药ETF10月份单月跌11% 规模逾200亿
中金财经 · 2025-11-05
广发中证香港创新药ETF10月份单月跌11% 规模逾200亿
【ETF动向】11月3日广发中证香港创新药ETF(QDII)基金涨1.02%，份额增加9600万份
证券之星 · 2025-11-04
【ETF动向】11月3日广发中证香港创新药ETF(QDII)基金涨1.02%，份额增加9600万份
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.25%，份额增加4.9亿份
证券之星 · 2025-10-31
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.25%，份额增加4.9亿份
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓，重仓信达生物
证券之星 · 2025-10-28
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓，重仓信达生物
【ETF动向】10月23日广发中证香港创新药ETF(QDII)基金跌2.19%，份额增加2亿份
中金财经 · 2025-10-24
【ETF动向】10月23日广发中证香港创新药ETF(QDII)基金跌2.19%，份额增加2亿份
【ETF动向】10月22日广发中证香港创新药ETF(QDII)基金跌2.49%，份额增加1.4亿份
证券之星 · 2025-10-23
【ETF动向】10月22日广发中证香港创新药ETF(QDII)基金跌2.49%，份额增加1.4亿份
前三季96%QDII正收益 广发中证香港创新药ETF涨112%
中金财经 · 2025-10-15
前三季96%QDII正收益 广发中证香港创新药ETF涨112%
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"515120","market":"SH","secType":"STK","nameCN":"创新药ETF","latestPrice":0.635,"timestamp":1770706799000,"preClose":0.627,"halted":0,"volume":588287800,"delay":0,"changeRate":0.0128,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.008,"latestTime":"02-10 14:59:59","open":0.627,"high":0.641,"low":0.624,"amount":373000000,"amplitude":0.0271,"askPrice":0.636,"askSize":166181,"bidPrice":0.635,"bidSize":25143,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"adjPreClose":0.627,"symbolType":"fund","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":0.69,"lowLimit":0.564,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.465108,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/515120","defaultTab":"news","newsList":[{"id":"2609580011","title":"【ETF动向】2月5日广发中证香港创新药ETF(QDII)基金跌0.95%，份额增加5.18亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2609580011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609580011?lang=zh_cn&edition=full","pubTime":"2026-02-06 06:31","pubTimestamp":1770330686,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日，广发中证香港创新药ETF(QDII)基金（513120）跌0.95%，成交额41.06亿元。当日份额增加了5.18亿份，最新份额为202.17亿份，近20个交易日份额增加9.7亿份。当日资金净流入7.88亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为255.34亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.42%，近一个月超额回报为0.07%，管理人为广发基金公司，基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600004733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2609311818","title":"【ETF动向】2月4日广发中证香港创新药ETF(QDII)基金涨1.28%，份额增加1.24亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2609311818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609311818?lang=zh_cn&edition=full","pubTime":"2026-02-05 06:31","pubTimestamp":1770244271,"startTime":"0","endTime":"0","summary":"证券之星消息，2月4日，广发中证香港创新药ETF(QDII)基金（513120）涨1.28%，成交额41.19亿元。当日份额增加了1.24亿份，最新份额为196.99亿份，近20个交易日份额增加4.3亿份。当日资金净流入2.69亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为247.46亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.62%，近一个月超额回报为-0.46%，管理人为广发基金公司，基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500003474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2607022139","title":"【ETF动向】1月30日广发中证香港创新药ETF(QDII)基金跌2.46%，份额增加7450万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2607022139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607022139?lang=zh_cn&edition=full","pubTime":"2026-01-31 06:31","pubTimestamp":1769812260,"startTime":"0","endTime":"0","summary":"证券之星消息，1月30日，广发中证香港创新药ETF(QDII)基金（513120）跌2.46%，成交额35.22亿元。当日份额增加了7450万份，最新份额为195.76亿份，近20个交易日份额增加1.01亿份。当日资金净流出5.27亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为250.59亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-34.17%，近一个月超额回报为-0.49%，管理人为广发基金公司，基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013100003957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2606520756","title":"【ETF动向】1月27日广发中证香港创新药ETF(QDII)基金涨0.39%，份额增加1.3亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606520756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606520756?lang=zh_cn&edition=full","pubTime":"2026-01-28 06:31","pubTimestamp":1769553063,"startTime":"0","endTime":"0","summary":"证券之星消息，1月27日，广发中证香港创新药ETF(QDII)基金（513120）涨0.39%，成交额36.09亿元。当日份额增加了1.3亿份，最新份额为194.73亿份，近20个交易日份额增加1.04亿份。当日资金净流入2.34亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为254.18亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-34.56%，近一个月超额回报为-0.33%，管理人为广发基金公司，基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800004795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2601858477","title":"【ETF动向】1月5日广发中证香港创新药ETF(QDII)基金涨5.95%，份额减少1.96亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601858477?lang=zh_cn&edition=full","pubTime":"2026-01-06 06:31","pubTimestamp":1767652276,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日，广发中证香港创新药ETF(QDII)基金（513120）涨5.95%，成交额68.08亿元。当日份额减少了1.96亿份，最新份额为192.78亿份，近20个交易日份额增加4.46亿份。当日资金净流入11.52亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为245.55亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.82%，近一个月超额回报为-0.85%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600004196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2595748105","title":"【ETF动向】12月30日广发中证香港创新药ETF(QDII)基金跌1.55%，份额增加9500万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595748105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595748105?lang=zh_cn&edition=full","pubTime":"2025-12-31 06:31","pubTimestamp":1767133876,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日，广发中证香港创新药ETF(QDII)基金（513120）跌1.55%，成交额29.59亿元。当日份额增加了9500万份，最新份额为194.75亿份，近20个交易日份额增加7.8亿份。当日资金净流出1793.35万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为237.36亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-31.82%，近一个月超额回报为-0.47%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100006066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2591627999","title":"【ETF动向】12月15日广发中证香港创新药ETF(QDII)基金跌3.23%，份额增加2.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2591627999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591627999?lang=zh_cn&edition=full","pubTime":"2025-12-16 06:31","pubTimestamp":1765837881,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日，广发中证香港创新药ETF(QDII)基金（513120）跌3.23%，成交额36.53亿元。当日份额增加了2.14亿份，最新份额为193.36亿份，近20个交易日份额增加7.42亿份。当日资金净流出7.85亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为242.55亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-32.31%，近一个月超额回报为-0.22%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600003509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2591615355","title":"12月15日博瑞医药跌6.09%，国泰上证科创板创新药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591615355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591615355?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:34","pubTimestamp":1765784071,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日博瑞医药跌6.09%，收盘报49.94元，换手率3.52%，成交量14.9万手，成交额7.56亿元。重仓博瑞医药的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为国泰基金的国泰上证科创板创新药ETF。国泰上证科创板创新药ETF目前规模为4.26亿元，最新净值0.9383，较上一交易日上涨0.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500012958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399006","000001.SH","000300.SH","515120","688166","399001","510880","159982","512510","399300","159967","000905.SH","515890","BK0239","510300","000688.SH","512880"],"gpt_icon":0},{"id":"2590618613","title":"【ETF动向】12月8日广发中证香港创新药ETF(QDII)基金跌0.98%，份额增加1.22亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590618613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590618613?lang=zh_cn&edition=full","pubTime":"2025-12-09 06:31","pubTimestamp":1765233066,"startTime":"0","endTime":"0","summary":"证券之星消息，12月8日，广发中证香港创新药ETF(QDII)基金（513120）跌0.98%，成交额42.56亿元。当日份额增加了1.22亿份，最新份额为189.56亿份，近20个交易日份额增加3.49亿份。当日资金净流出2.41亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为249.66亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.45%，近一个月超额回报为-0.11%，管理人为广发基金公司，基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900002812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2588972027","title":"【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金跌1.73%，份额增加1.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2588972027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588972027?lang=zh_cn&edition=full","pubTime":"2025-12-04 06:31","pubTimestamp":1764801064,"startTime":"0","endTime":"0","summary":"证券之星消息，12月3日，广发中证香港创新药ETF(QDII)基金（513120）跌1.73%，成交额34.02亿元。当日份额增加了1.14亿份，最新份额为188.09亿份，近20个交易日份额增加6.78亿份。当日资金净流出3.17亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为245.21亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.08%，近一个月超额回报为-0.01%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400002559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2583548343","title":"【ETF动向】11月13日广发中证香港创新药ETF(QDII)基金涨4.2%，份额减少1.89亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583548343","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583548343?lang=zh_cn&edition=full","pubTime":"2025-11-14 06:31","pubTimestamp":1763073071,"startTime":"0","endTime":"0","summary":"证券之星消息，11月13日，广发中证香港创新药ETF(QDII)基金（513120）涨4.2%，成交额103.03亿元。当日份额减少了1.89亿份，最新份额为185.53亿份，近20个交易日份额增加20.24亿份。当日资金净流入8.46亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为261.93亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-35.71%，近一个月超额回报为0.19%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400004244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2582838657","title":"【ETF动向】11月10日广发中证香港创新药ETF(QDII)基金涨1.36%，份额增加1.12亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582838657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582838657?lang=zh_cn&edition=full","pubTime":"2025-11-11 06:31","pubTimestamp":1762813868,"startTime":"0","endTime":"0","summary":"证券之星消息，11月10日，广发中证香港创新药ETF(QDII)基金（513120）涨1.36%，成交额64.98亿元。当日份额增加了1.12亿份，最新份额为186.07亿份，近20个交易日份额增加21.36亿份。当日资金净流入4.72亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为247.23亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-31.38%，近一个月超额回报为1.38%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100002917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2581497850","title":"【ETF动向】11月6日广发中证香港创新药ETF(QDII)基金涨0.45%，份额增加1.6亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2581497850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581497850?lang=zh_cn&edition=full","pubTime":"2025-11-07 06:31","pubTimestamp":1762468268,"startTime":"0","endTime":"0","summary":"证券之星消息，11月6日，广发中证香港创新药ETF(QDII)基金（513120）涨0.45%，成交额60.52亿元。当日份额增加了1.6亿份，最新份额为182.91亿份，近20个交易日份额增加21.08亿份。当日资金净流入3.49亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为246.36亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-34.11%，近一个月超额回报为0.11%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700004346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2581741394","title":"广发中证香港创新药ETF10月份单月跌11% 规模逾200亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2581741394","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581741394?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:37","pubTimestamp":1762331821,"startTime":"0","endTime":"0","summary":"中国经济网北京11月5日讯 今年10月份，在港股高位震荡的影响下，广发中证香港创新药ETF 净值收益率下跌达11.61%。从第一大重仓股信达生物来看，该股在10月份下跌了9.75%，而康方生物更是下跌超过19%。 此外，刘杰管理的广发中证香港创新药ETF发起式联接A/C也在10月份分别下跌逾11%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202511/05/20251105582837.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202511/05/20251105582837.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251105/31769750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["515120"],"gpt_icon":0},{"id":"2580555221","title":"【ETF动向】11月3日广发中证香港创新药ETF(QDII)基金涨1.02%，份额增加9600万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2580555221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580555221?lang=zh_cn&edition=full","pubTime":"2025-11-04 06:31","pubTimestamp":1762209069,"startTime":"0","endTime":"0","summary":"证券之星消息，11月3日，广发中证香港创新药ETF(QDII)基金（513120）涨1.02%，成交额120.66亿元。当日份额增加了9600万份，最新份额为173.99亿份，近20个交易日份额增加9.92亿份。当日资金净流入4.59亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为239.27亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-32.4%，近一个月超额回报为1.37%，管理人为广发基金公司，基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400004380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2579210928","title":"【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.25%，份额增加4.9亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2579210928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579210928?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:31","pubTimestamp":1761863486,"startTime":"0","endTime":"0","summary":"证券之星消息，10月30日，广发中证香港创新药ETF(QDII)基金（513120）跌3.25%，成交额58.85亿元。当日份额增加了4.9亿份，最新份额为173.45亿份，近20个交易日份额增加8.38亿份。当日资金净流入2.77亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为228.85亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-33.36%，近一个月超额回报为0.13%，管理人为广发基金公司，基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100008462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2578670634","title":"广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓，重仓信达生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2578670634","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578670634?lang=zh_cn&edition=full","pubTime":"2025-10-28 07:33","pubTimestamp":1761608010,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日广发基金旗下刘杰管理的广发中证香港创新药交易型开放式指数基金(QDII)公布三季报，近1年净值增长率69.75%。与上一季度相比，该基金前十大重仓股新增科伦博泰生物-B；并对信达生物增仓851.25万股，为该基金第一大重仓股；再鼎医药等退出前十大重仓股；详细数据如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800008213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2097828805.USD","BK1161","LU2488822045.USD","LU2328871848.SGD","LU2242644610.SGD","BK1583","LU0455707207.USD","LU2097828474.EUR","01801","LU0502904849.HKD","LU2097828557.USD","515120","LU2097828631.EUR","BK1589","LU1969619763.USD","LU2097828714.EUR"],"gpt_icon":0},{"id":"2577553115","title":"【ETF动向】10月23日广发中证香港创新药ETF(QDII)基金跌2.19%，份额增加2亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577553115","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577553115?lang=zh_cn&edition=full","pubTime":"2025-10-24 08:00","pubTimestamp":1761264029,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日，广发中证香港创新药ETF(QDII)基金(513120)跌2.19%，成交额57.64亿元。当日份额增加了2亿份，最新份额为168.62亿份，近20个交易日份额增加4.8亿份。当日资金净流出1.69亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为224.91亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立(2022-07-01)以来超额回报为-33.77%，近一个月超额回报为0.04%，管理人为广发基金公司，基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251024/31731935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","BK4550","BK4585","515120","FDN"],"gpt_icon":0},{"id":"2577038310","title":"【ETF动向】10月22日广发中证香港创新药ETF(QDII)基金跌2.49%，份额增加1.4亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577038310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577038310?lang=zh_cn&edition=full","pubTime":"2025-10-23 06:30","pubTimestamp":1761172259,"startTime":"0","endTime":"0","summary":"证券之星消息，10月22日，广发中证香港创新药ETF(QDII)基金（513120）跌2.49%，成交额52.4亿元。当日份额增加了1.4亿份，最新份额为166.62亿份，近20个交易日份额增加3.98亿份。当日资金净流出2.91亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为226.6亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数，成立（2022-07-01）以来超额回报为-34.39%，近一个月超额回报为-0%，管理人为广发基金公司，基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300004396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2575292982","title":"前三季96%QDII正收益 广发中证香港创新药ETF涨112%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292982","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575292982?lang=zh_cn&edition=full","pubTime":"2025-10-15 08:04","pubTimestamp":1760486660,"startTime":"0","endTime":"0","summary":"中国经济网北京10月15日讯 今年前三季，全市场650只有可比业绩的QDII基金中，共有624只基金净值上涨，占比96%；有26只基金净值下跌。 跌幅榜上，前三季垫底QDII基金的主要为房地产、原油及油气类产品。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202510/15/20251015759452.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202510/15/20251015759452.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251015/31706468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["515120"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770713956754,"stockEarnings":[{"period":"1week","weight":0.0279},{"period":"1month","weight":-0.0656},{"period":"3month","weight":-0.0614},{"period":"6month","weight":-0.1043},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0032}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药ETF,515120,创新药ETF股票,创新药ETF股票老虎,创新药ETF股票老虎国际,创新药ETF行情,创新药ETF股票行情,创新药ETF股价,创新药ETF股市,创新药ETF股票价格,创新药ETF股票交易,创新药ETF股票购买,创新药ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}